Evidence map›Paper›PMID 30925931›Full record

ArticleBMC research notes2019

Novel binding partners for Prenylated Rab Acceptor 1 identified by a split-ubiquitin yeast two-hybrid screen.

Ameair Abu Irqeba, Judith Mosinger Ogilvie

Abstract read
In one paragraph

Article in BMC research notes, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ameair Abu IrqebaBiology Department, Saint Louis University, Macelwane Hall, 3507 Laclede Ave, St. Louis, MO, 63103, USA.
Judith Mosinger OgilvieBiology Department, Saint Louis University, Macelwane Hall, 3507 Laclede Ave, St. Louis, MO, 63103, USA. judith.ogilvie@slu.edu.ORCID http://orcid.org/0000-0001-9499-9975

Funding

A model of neuronal cell development and differentiation: Mouse rod photoreceptorR15HD064269 · NICHD · SAINT LOUIS UNIVERSITY · PI OGILVIE, JUDITH MOSINGER · 2010 to 2010
$221k
NICHD NIH HHS R15 HD064269NIH HHS R15HD064269
6 · The paper itself

Abstract

objectivePrenylated Rab Acceptor 1 (PRA1) is a transmembrane protein localized to the early secretory pathway. It has been found to interact with an array of Rab GTPases, leading to its hypothesized function in the recycling of Rab GTPases. However, all previous strategies used to screen for novel interacting partners have utilized a classic yeast two-hybrid approach that requires both bait and its potential binding partners to be cytosolic proteins. In the split-ubiquitin yeast two-hybrid screen, a protein interaction leads to the re-constitution of ubiquitin, which is followed by proteolytic release of a transcription activator that migrates to the nucleus alone. This allows for bait and/or prey to be integral membrane protein(s). To better understand the in vivo function of PRA1, we took an unbiased approach that screened PRA1 against a normalized mouse neuronal cDNA library using this variant of the classic screening strategy.

resultsWe report 41 previously unidentified potential PRA1 binding partners revealed by this screen and validate the screen by confirming three of these interactions using a bi-molecular fluorescence complementation assay in mammalian cells. The identified proteins reside throughout the secretory pathway and are both membrane-bound and cytosolic in their identity, suggesting alternative functions for PRA1.

Indexed as

Two-Hybrid System TechniquesAnimalsCarrier ProteinsCell NucleusChlorocebus aethiopsCOS CellsGene LibraryGTP-Binding ProteinsMembrane ProteinsMiceNeuronsProtein BindingUbiquitinVesicular Transport ProteinsCarrier ProteinsGTP-Binding ProteinsMembrane ProteinsUbiquitinVesicular Transport ProteinsMousePhotoreceptorPRA1Protein interactionRabac1Split-ubiquitin yeast two-hybrid screenYip3

Identifiers

PMID30925931
PMCPMC6441142

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.